Ann: Appendix 4E and Annual Report, page-68

  1. 239 Posts.
    lightbulb Created with Sketch. 1196
    Dr Tillet I presume,
    The CEO of Race Oncology

    I am intrigued to see you posting on the IMU threads ...

    I would be interested to hear your thoughts on Imugene's clinical trial of onCARlytics (CF33-CD19), an innovative oncolytic virotherapy designed to target advanced solid tumours and its potential to provide a universal therapy for the treatment of cancer.

    Fascinating stuff don't you think.

    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.2¢
Change
-0.001(7.69%)
Mkt cap ! $89.60M
Open High Low Value Volume
1.3¢ 1.3¢ 1.2¢ $125.5K 9.910M

Buyers (Bids)

No. Vol. Price($)
29 9152522 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 11548179 22
View Market Depth
Last trade - 11.29am 30/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.